Advertisement
Screener

VERICEL CORPORATION (VCEL) EBITDA

VERICEL CORPORATION (VCEL) EBITDA

  • 2026-06-30: Basis Reported; EBITDA $4.05M*; Operating income $434.00K; Depreciation and amortization $3.62M*.
  • 2026-03-31: Basis Reported; EBITDA -$4.8M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA $25.5M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA $6.39M*; Operating income $3.45M; Depreciation and amortization $2.94M*.

Complete source-backed ebitda history.

Available history
2009-06-30 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported$4.05M*$434.00K$3.62M*$77.46M5.23%*$1.93M*$16.19M*$21.05M$7.49M$48.48M(m)
2026-03-31Reported-$4.8M(m)(m)(m)-7.01%$1.26M$16.38M$19.16M$8.10M$49.23M(m)
2025-12-31Reported$25.5M(m)(m)(m)27.45%(m)(m)(m)(m)(m)(m)
2025-09-30Reported$6.39M*$3.45M$2.94M*$67.50M9.47%*$2.63M*$22.08M*$17.92M$6.32M$39.82M(m)
2025-06-30Reported$797.00K*-$2.03M$2.83M*$63.24M1.26%*$8.13M*$8.21M*$16.63M$6.73M$41.91M(m)
2025-03-31Reported-$10.11M(m)(m)(m)-19.21%$14.21M$6.60M$16.32M$7.26M$41.80M(m)
2024-12-31Reported$19.96M(m)(m)(m)26.48%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$1.14M*-$2.46M$1.33M*$57.91M-1.97%*$19.41M*$10.18M*$16.25M$6.09M$38.02M$0.00
2024-06-30Reported-$4.71M*-$6.03M$1.32M*$52.66M-8.94%*$16.76M*$18.54M*$16.06M$7.36M$35.27M(m)
2024-03-31Reported-$4.09M(m)(m)(m)-7.97%$14.02M$7.20M$15.93M$6.42M$34.40M(m)
2023-12-31Reported$13.88M(m)(m)(m)21.36%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$3.90M*-$5.06M$1.15M*$45.58M-8.56%*$6.57M*$7.17M*$14.97M$5.68M$29.99M-$286.00K
2023-06-30Reported-$4.79M*-$5.96M$1.17M*$45.92M-10.43%*$4.20M*$10.20M*$15.98M$5.25M$30.65M(m)
2023-03-31Reported-$7.02M(m)(m)(m)-17.11%$1.41M$7.86M$14.50M$5.21M$29.48M(m)
2022-12-31Reported$7.12M(m)(m)(m)13.52%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$5.79M(m)(m)(m)-15.10%$1.41M*$4.10M*$13.32M$5.05M$26.98M$21.00K
2022-06-30Reported-$7.98M(m)(m)(m)-21.67%$1.98M*$3.14M*$14.19M$4.79M$27.14M$0.00
2022-03-31Reported-$6.4M(m)(m)(m)-17.85%$3.08M$3.47M$12.62M$4.86M$25.86M$0.00
2021-12-31Reported$4.92M(m)(m)(m)10.46%(m)(m)(m)(m)(m)(m)
2021-09-30Reported-$4.26M(m)(m)(m)-12.64%$2.46M*$3.63M*$12.41M$4.28M$22.77M$0.00
2021-06-30Reported-$3.03M(m)(m)(m)-7.83%$2.12M*$4.77M*$12.61M$4.45M$26.19M$72.00K
2021-03-31Reported-$2.49M(m)(m)(m)-7.42%$2.34M$10.09M$11.58M$3.63M$22.66M$143.00K
2020-12-31Reported$13.02M(m)(m)(m)29.43%(m)(m)(m)(m)(m)(m)
2020-09-30Reported$4.09M*$3.52M$570.00K*$31.02M13.18%*$370.00K*$4.57M*$9.79M$2.91M$16.04M$0.00
2020-06-30Reported-$7.81M*-$8.36M$546.00K*$20.01M-39.03%*$469.00K*-$3.02M*$8.66M$3.23M$16.49M$0.00
2020-03-31Reported-$4.54M(m)(m)(m)-17.03%$717.00K$4.69M$9.92M$3.76M$18.07M$0.00
2019-12-31Reported$9.74M(m)(m)(m)24.72%(m)(m)(m)(m)(m)(m)
2019-09-30Reported$3.57M*$3.10M$476.00K*$30.50M11.72%*$1.03M*$7.89M*$9.32M$3.10M$14.98M(m)
2019-06-30Reported-$19.83M*-$20.20M$374.00K*$26.15M-75.81%*$992.00K*-$18.38M*$9.02M$21.07M$16.26M(m)
2019-03-31Reported-$3.03M(m)(m)(m)-13.91%$232.00K$154.00K$8.64M$3.01M$13.52M(m)
2018-12-31Reported$6.29M(m)(m)(m)20.07%(m)(m)(m)(m)(m)(m)
2018-09-30Reported-$1.02M*-$1.34M$320.00K*$22.48M-4.52%*$1.12M*$2.01M*(m)$3.11M$12.57M(m)
2018-06-30Reported-$3.86M*-$4.25M$386.00K*$19.01M-20.30%*$795.00K*-$5.44M*(m)$3.74M$11.79M(m)
2018-03-31Reported-$3.9M(m)(m)(m)-21.61%$184.00K$405.00K(m)$3.73M$10.95M(m)
2017-12-31Reported$1.62M(m)(m)(m)7.29%(m)(m)(m)(m)(m)(m)
2017-09-30Reported-$3.63M*-$4.03M$402.00K*$14.26M-25.45%*(m)-$5.24M*(m)$2.92M$8.19M(m)
2017-06-30Reported-$2.15M*-$2.52M$375.00K*$16.95M-12.66%*(m)-$5.65M*(m)$2.97M$8.83M(m)
2017-03-31Reported-$9.21M(m)(m)(m)-98.43%(m)-$3.12M(m)$3.47M$8.41M(m)
2016-12-31Reported-$5.4M(m)(m)(m)-32.66%(m)(m)(m)(m)(m)(m)
2016-09-30Reported-$5.91M*-$6.38M$470.00K*(m)(m)(m)-$4.18M*(m)$3.44M$7.01M(m)
2016-06-30Reported-$4.51M*-$4.98M$478.00K*(m)(m)(m)(m)(m)$4.06M$6.45M(m)
2016-03-31Reported-$1.55M(m)(m)(m)-10.97%(m)(m)(m)$3.54M$6.00M(m)
2015-12-31Reported-$4.55M(m)(m)(m)-29.49%(m)(m)(m)(m)(m)(m)
2015-09-30Reported-$4.37M*-$4.88M$510.00K*(m)(m)$775.00K*(m)(m)$3.74M$5.67M(m)
2015-06-30Reported-$1.92M*-$2.27M$344.00K*(m)(m)(m)(m)(m)$3.37M$5.58M(m)
2015-03-31Reported-$4.24M(m)(m)(m)-39.12%(m)(m)(m)$4.38M$5.48M(m)
2014-12-31Reported-$2.09M(m)(m)(m)-14.21%(m)(m)(m)(m)(m)(m)
2014-09-30Reported-$7.77M*-$8.02M$250.00K*(m)(m)$68.00K*(m)(m)$7.83M$4.31M(m)
2014-06-30Reported-$8.37M*-$8.52M$149.00K*(m)(m)(m)(m)(m)$4.36M$3.58M(m)
2014-03-31Reported-$4.55M(m)(m)(m)(m)(m)(m)(m)$3.27M$1.37M(m)
2013-12-31Reported-$4.82M(m)(m)(m)-60275.00%(m)(m)(m)(m)(m)(m)
2013-09-30Reported-$3.53M*-$3.64M$112.00K*(m)(m)$0.00*(m)(m)$2.58M$1.07M(m)
2013-06-30Reported-$5.11M*-$5.23M$125.00K*(m)(m)$22.00K*(m)(m)$3.68M$1.56M(m)
2013-03-31Reported-$7.02M(m)(m)(m)-87687.50%$18.00K(m)(m)$5.54M$1.63M(m)
2012-12-31Reported-$7.46M(m)(m)(m)-39236.84%(m)(m)(m)(m)(m)(m)
2012-09-30Reported-$8.14M*-$8.29M$146.00K*(m)(m)$83.00K*(m)(m)$6.15M$2.14M(m)
2012-06-30Reported-$9.14M*-$9.30M$162.00K*(m)(m)$4.00K*(m)(m)$7.07M$2.23M(m)
2012-03-31Reported-$8.38M(m)(m)(m)-418950.00%$82.00K(m)(m)$6.80M$1.76M(m)
2011-12-31Reported-$7.65M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2011-09-30Reported-$7.27M*-$7.44M$168.00K*(m)(m)$391.00K*(m)(m)$5.75M$1.70M(m)
2011-06-30Reported-$7.34M*-$7.51M$162.00K*(m)(m)$264.00K*(m)(m)$5.30M$2.20M(m)
2011-03-31Reported-$6.13M(m)(m)(m)-68066.67%$148.00K(m)(m)$4.37M$1.90M(m)
2010-09-30Reported-$5.72M*-$5.85M$129.00K*(m)(m)$68.00K*(m)(m)$4.17M$1.69M(m)
2010-06-30Reported(m)-$5.14M(m)(m)(m)(m)(m)(m)$3.62M$1.52M(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported$22.59M(m)(m)(m)8.18%$27.16M$51.91M$70.66M$27.56M$166.99M$859.00K
2024-12-31Reported$10.02M(m)(m)(m)4.23%$63.97M$58.16M$65.12M$24.80M$142.79M$148.00K
2023-12-31Reported-$1.83M(m)(m)(m)-0.93%$20.01M$35.31M$61.94M$21.04M$121.00M$814.00K
2022-12-31Reported-$13.08M(m)(m)(m)-7.99%$7.60M$17.69M$54.58M$19.94M$106.90M$721.00K
2021-12-31Reported-$4.89M(m)(m)(m)-3.19%$7.92M$29.04M$50.16M$16.29M$97.59M-$111.00K
2021-09-30Rolling(m)$294.00K*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-06-30Rolling(m)$8.77M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-03-31Rolling(m)$4.14M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-12-31Reported$4.76M(m)(m)(m)3.90%$2.63M$17.57M$39.95M$13.02M$68.84M$180.00K
2020-12-31Rolling(m)$2.37M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-09-30Rolling(m)-$707.00K*(m)$117.10M*(m)(m)(m)(m)(m)(m)(m)
2020-06-30Rolling(m)-$1.13M*(m)$116.58M*(m)(m)(m)(m)(m)(m)(m)
2020-03-31Rolling(m)-$12.97M*(m)$122.72M*(m)(m)(m)(m)(m)(m)(m)
2019-12-31Reported-$9.55M(m)(m)(m)-8.10%$2.62M-$7.18M$37.57M$30.39M$61.14M$0.00
2019-12-31Rolling(m)-$11.25M*(m)$117.85M*(m)(m)(m)(m)(m)(m)(m)
2019-09-30Rolling(m)-$14.47M*(m)$109.80M*(m)(m)(m)(m)(m)(m)(m)
2019-06-30Rolling(m)-$18.90M*(m)$101.78M*(m)(m)(m)(m)(m)(m)(m)
2019-03-31Rolling(m)-$2.94M*(m)$94.64M*(m)(m)(m)(m)(m)(m)(m)
2018-12-31Reported-$2.48M(m)(m)(m)-2.73%$2.68M-$412.00K$32.16M$13.60M$49.01M$0.00
2018-12-31Rolling(m)-$3.91M*(m)$90.86M*(m)(m)(m)(m)(m)(m)(m)
2018-09-30Rolling(m)-$8.71M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-06-30Rolling(m)-$11.41M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-03-31Rolling(m)-$9.68M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2017-12-31Reported-$13.37M(m)(m)(m)-21.31%$1.51M-$13.18M$30.35M$12.94M$35.61M$0.00
2017-12-31Rolling(m)-$14.98M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2017-09-30Rolling(m)-$14.98M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2017-06-30Rolling(m)-$17.33M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2017-03-31Rolling(m)-$19.80M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2016-12-31Reported-$17.36M(m)(m)(m)-31.92%$1.42M-$19.89M$28.31M$15.29M$27.39M$0.00
2016-12-31Rolling(m)-$12.16M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2016-09-30Rolling(m)-$18.31M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2016-06-30Rolling(m)-$16.81M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2016-03-31Rolling(m)-$14.09M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2015-12-31Reported-$15.08M(m)(m)(m)-29.47%$2.43M-$13.35M(m)$18.89M$22.48M$0.00
2015-12-31Rolling(m)-$16.67M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2015-09-30Rolling(m)-$14.06M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2015-06-30Rolling(m)-$17.20M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2015-03-31Rolling(m)-$23.46M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-12-31Reported-$22.78M(m)(m)(m)-79.12%$829.00K(m)(m)$21.26M$13.77M$0.00
2014-12-31Rolling(m)-$23.53M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-12-31Reported-$20.48M(m)(m)(m)-107763.16%$40.00K(m)(m)$15.10M$5.88M$0.00
2013-09-30Rolling(m)-$23.66M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-06-30Rolling(m)-$28.30M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-03-31Rolling(m)-$32.37M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-12-31Reported-$33.11M(m)(m)(m)-157671.43%$273.00K(m)(m)$26.02M$7.75M(m)
2012-12-31Rolling(m)-$33.76M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-09-30Rolling(m)-$33.98M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-06-30Rolling(m)-$33.13M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-03-31Rolling(m)-$31.34M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2011-12-31Reported-$28.39M(m)(m)(m)-157738.89%$1.03M(m)(m)$21.33M$7.72M(m)
2011-12-31Rolling(m)-$29.04M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2010-06-30Reported-$17.21M(m)(m)(m)-19339.33%$120.00K(m)(m)$12.66M$5.20M(m)
2009-06-30Reported-$15.47M(m)(m)(m)-8497.25%$35.00K(m)(m)$11.29M$4.95M(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Greenland Mines Ltd (GRML)United States$2.362B
Immunocore Holdings plc (IMCR)$1.613B-90.43
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80